Zobrazeno 11 - 20
of 35
pro vyhledávání: '"Sweta Desai"'
Autor:
Katayoun Rezvani, Todd A. Fehniger, Elizabeth J. Shpall, Oswaldo Keith Okamoto, Wolfgang Fischer, Martin Treder, Joachim Koch, Yago L. Nieto, Richard E. Champlin, Luis Muniz-Feliciano, Ken Chen, Natalie W. Fowlkes, Natalia Baran, Yifei Shen, Qi Miao, Vakul Mohanty, Vandana Nandivada, Rong Cai, Sonny O. Ang, Enli Liu, Pamela Wong, Nadima Uprety, Emily L. Ensley, Mayra Shanley, Hila Shaim, Li Li, Timothy Schappe, Mayela Carolina Mendt, Francesca Wei Inng Lim, Sweta Desai, Ana Karen Nunez Cortes, May Daher, Ethan McClain, Carly C. Neal, Luciana Garcia Melo, Mark Foster, Rafet Basar, Michelle Becker-Hapak, Melissa M. Berrien-Elliott, Pinaki P. Banerjee, Mecit Kaplan, Nancy D. Marin, Lucila N. Kerbauy
Supplementary Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262671738d0b192438cbddfbf2755311
https://doi.org/10.1158/1078-0432.22481513.v1
https://doi.org/10.1158/1078-0432.22481513.v1
Autor:
Katayoun Rezvani, Todd A. Fehniger, Elizabeth J. Shpall, Oswaldo Keith Okamoto, Wolfgang Fischer, Martin Treder, Joachim Koch, Yago L. Nieto, Richard E. Champlin, Luis Muniz-Feliciano, Ken Chen, Natalie W. Fowlkes, Natalia Baran, Yifei Shen, Qi Miao, Vakul Mohanty, Vandana Nandivada, Rong Cai, Sonny O. Ang, Enli Liu, Pamela Wong, Nadima Uprety, Emily L. Ensley, Mayra Shanley, Hila Shaim, Li Li, Timothy Schappe, Mayela Carolina Mendt, Francesca Wei Inng Lim, Sweta Desai, Ana Karen Nunez Cortes, May Daher, Ethan McClain, Carly C. Neal, Luciana Garcia Melo, Mark Foster, Rafet Basar, Michelle Becker-Hapak, Melissa M. Berrien-Elliott, Pinaki P. Banerjee, Mecit Kaplan, Nancy D. Marin, Lucila N. Kerbauy
Supplementary Fig. S3. Differentiation of ML NK cells and Preactivated-Expanded CB-NK cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0186715f267ce29bfa8b882658906da
https://doi.org/10.1158/1078-0432.22481537
https://doi.org/10.1158/1078-0432.22481537
Autor:
Katayoun Rezvani, Todd A. Fehniger, Elizabeth J. Shpall, Oswaldo Keith Okamoto, Wolfgang Fischer, Martin Treder, Joachim Koch, Yago L. Nieto, Richard E. Champlin, Luis Muniz-Feliciano, Ken Chen, Natalie W. Fowlkes, Natalia Baran, Yifei Shen, Qi Miao, Vakul Mohanty, Vandana Nandivada, Rong Cai, Sonny O. Ang, Enli Liu, Pamela Wong, Nadima Uprety, Emily L. Ensley, Mayra Shanley, Hila Shaim, Li Li, Timothy Schappe, Mayela Carolina Mendt, Francesca Wei Inng Lim, Sweta Desai, Ana Karen Nunez Cortes, May Daher, Ethan McClain, Carly C. Neal, Luciana Garcia Melo, Mark Foster, Rafet Basar, Michelle Becker-Hapak, Melissa M. Berrien-Elliott, Pinaki P. Banerjee, Mecit Kaplan, Nancy D. Marin, Lucila N. Kerbauy
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6e79870ae17c10dc5685064ad99d16
https://doi.org/10.1158/1078-0432.22481516.v1
https://doi.org/10.1158/1078-0432.22481516.v1
Autor:
Katayoun Rezvani, Todd A. Fehniger, Elizabeth J. Shpall, Oswaldo Keith Okamoto, Wolfgang Fischer, Martin Treder, Joachim Koch, Yago L. Nieto, Richard E. Champlin, Luis Muniz-Feliciano, Ken Chen, Natalie W. Fowlkes, Natalia Baran, Yifei Shen, Qi Miao, Vakul Mohanty, Vandana Nandivada, Rong Cai, Sonny O. Ang, Enli Liu, Pamela Wong, Nadima Uprety, Emily L. Ensley, Mayra Shanley, Hila Shaim, Li Li, Timothy Schappe, Mayela Carolina Mendt, Francesca Wei Inng Lim, Sweta Desai, Ana Karen Nunez Cortes, May Daher, Ethan McClain, Carly C. Neal, Luciana Garcia Melo, Mark Foster, Rafet Basar, Michelle Becker-Hapak, Melissa M. Berrien-Elliott, Pinaki P. Banerjee, Mecit Kaplan, Nancy D. Marin, Lucila N. Kerbauy
Purpose:Natural killer (NK)-cell recognition and function against NK-resistant cancers remain substantial barriers to the broad application of NK-cell immunotherapy. Potential solutions include bispecific engagers that target NK-cell activity via an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f8e65e1e920150dcbd7408adbc0a3d
https://doi.org/10.1158/1078-0432.c.6530711
https://doi.org/10.1158/1078-0432.c.6530711
Autor:
Nancy L. Bartlett, Felicia Gomez, Matthew Mosior, Malachi Griffith, Anne Fischer, Michelle Becker-Hapak, Mark P. Foster, Melissa M. Berrien-Elliott, Alina D. Schmidt, Marcus Watkins, Amanda F. Cashen, Kilannin Krysiak, Kami J. Maddocks, Nina D. Wagner-Johnston, Jingqin Luo, Obi L. Griffith, Zachary L. Skidmore, Todd A. Fehniger, Sweta Desai, Jeffrey P. Ward
Publikováno v:
Blood
New therapies are needed for patients with relapsed/refractory (rel/ref) diffuse large B-cell lymphoma (DLBCL) who do not benefit from or are ineligible for stem cell transplant and chimeric antigen receptor therapy. The CD30-targeted, antibody-drug
Autor:
Ethan McClain, Sweta Desai, Amanda F. Cashen, Mark P. Foster, Peter Westervelt, Patrick Soon-Shiong, Michelle Becker-Hapak, Keith Stockerl-Goldstein, Jeffrey S. Miller, Miriam T. Jacobs, Mark A. Schroeder, Pamela Wong, Camille N. Abboud, Patrick Pence, Geoffrey L. Uy, Feng Gao, Claudio G. Brunstein, Melissa M. Berrien-Elliott, Meagan A. Jacoby, Iskra Pusic, Sarah Cooley, John F. DiPersio, Todd A. Fehniger
Publikováno v:
Blood. 139:1177-1183
Natural killer (NK) cells are a promising alternative to T cells for cancer immunotherapy. Adoptive therapies with allogeneic, cytokine-activated NK cells are being investigated in clinical trials. However, the optimal cytokine support after adoptive
Autor:
Pamela Wong, Jin-An Jiao, Timothy Schappe, Gilles M. Leclerc, Sweta Desai, Gabriela J. Muniz, Melissa M. Berrien-Elliott, Mark P. Foster, Lynne Marsala, Pallavi Chaturvedi, Carly Neal, Niraj Shrestha, Christian A. Echeverri, Xiaoyun Zhu, David A. Russler-Germain, Caitlin A. Prendes, Catherine M. Spanoudis, Todd A. Fehniger, Ethan McClain, Jack O. Egan, Michael J. Dee, Peter R. Rhode, Hing C. Wong, Jennifer Tran, Laritza L. Ramirez, Ryan P. Sullivan, Lijing You, Victor L. Gallo, Julia A. Wagner, Emily K. Jeng, Michelle Becker-Hapak, Patrick Pence
Publikováno v:
Cancer Immunol Res
Natural killer (NK) cells are a promising cellular therapy for cancer, with challenges in the field including persistence, functional activity, and tumor recognition. Briefly, priming blood NK cells with recombinant human (rh)IL-12, rhIL-15, and rhIL
Autor:
Amanda F. Cashen, Matthew L. Cooper, Carly Neal, Camille N. Abboud, Feng Gao, Sweta Desai, Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Celia C. Cubitt, Timothy Schappe, Pamela Wong, Mark A. Schroeder, John F. DiPersio, Peter Westervelt, Julia A. Wagner, Jennifer A. Foltz, Meagan A. Jacoby, Natalia Jaeger, Iskra Pusic, Mark P. Foster, Geoffrey L. Uy, Todd A. Fehniger, Ethan McClain, Rizwan Romee, Keith Stockerl-Goldstein, Sridhar Nonavinkere Srivatsan
Publikováno v:
Cancer Discov
Natural killer (NK) cells are an emerging cancer cellular therapy and potent mediators of antitumor immunity. Cytokine-induced memory-like (ML) NK cellular therapy is safe and induces remissions in patients with acute myeloid leukemia (AML). However,
Autor:
Melissa M. Berrien-Elliott, Jennifer A. Foltz, David A. Russler-Germain, Carly C. Neal, Jennifer Tran, Margery Gang, Pamela Wong, Bryan Fisk, Celia C. Cubitt, Nancy D. Marin, Alice Y. Zhou, Miriam T. Jacobs, Mark Foster, Timothy Schappe, Ethan McClain, Samantha Kersting-Schadek, Sweta Desai, Patrick Pence, Michelle Becker-Hapak, Jeremy Eisele, Matthew Mosior, Lynne Marsala, Obi L. Griffith, Malachi Griffith, Saad M. Khan, David H. Spencer, John F. DiPersio, Rizwan Romee, Geoffrey L. Uy, Camille N. Abboud, Armin Ghobadi, Peter Westervelt, Keith Stockerl-Goldstein, Mark A. Schroeder, Fei Wan, Wen-Rong Lie, Patrick Soon-Shiong, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger
Publikováno v:
Sci Transl Med
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK cell function, expansion, and persistence remain key challenges for optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d5b150b9fb46a2a7f0c16ecb5e95ee
https://europepmc.org/articles/PMC9210521/
https://europepmc.org/articles/PMC9210521/
Autor:
Cody A. Ramirez, Felix Frenkel, Michelle Becker-Hapak, Erica K. Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L. Skidmore, Marcus P. Watkins, Thomas B. Mooney, Jason R. Walker, Kilannin Krysiak, David A. Russler-Germain, Felicia Gomez, Catrina C. Fronick, Robert S. Fulton, Robert D. Schreiber, Neha Mehta-Shah, Amanda F. Cashen, Brad S. Kahl, Ravshan Ataullakhanov, Nancy L. Bartlett, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger
Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that ‘polyvalent’ vaccines could be engineered for the personalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b922592ebecde45a7413123710bd2365
https://doi.org/10.1101/2022.01.06.22268805
https://doi.org/10.1101/2022.01.06.22268805